<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Dysregulation of imprinted genes on human chromosome 11p15 has been implicated in <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> (BWS), an <z:hpo ids='HP_0001548'>overgrowth</z:hpo> syndrome associated with <z:e sem="disease" ids="C1705254" disease_type="Disease or Syndrome" abbrv="">congenital malformations</z:e> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> predisposition </plain></SENT>
<SENT sid="1" pm="."><plain>The molecular basis of BWS is complex and <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The syndrome is associated with alterations in two distinct imprinting domains on 11p15: a telomeric domain containing the H19 and IGF2 genes and a centromeric domain including the KCNQ1OT1 and CDKNIC genes </plain></SENT>
<SENT sid="3" pm="."><plain>It has been postulated that disorders of imprinting in the telomeric domain are associated with <z:hpo ids='HP_0001548'>overgrowth</z:hpo> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> predisposition, whereas those in the centromeric domain involve malformations but not <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development </plain></SENT>
<SENT sid="4" pm="."><plain>In this study of 125 BWS cases, we confirm the association of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with constitutional defects in the 11p15 telomeric domain; six of 21 BWS cases with <z:mp ids='MP_0008867'>uniparental disomy</z:mp> (UPD) of 11p15 developed <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and one of three of the rare BWS subtype with hypermethylation of the H19 gene developed <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Most importantly, we find that five of 32 individuals with BWS and imprinting defects in the centromeric domain developed <z:hpo ids='HP_0002898'>embryonal tumors</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, the type of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> observed in BWS cases with telomeric defects are different from those seen in BWS cases with defects limited to the centromeric domain </plain></SENT>
<SENT sid="7" pm="."><plain>Whereas <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e> was the most frequent <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> seen in BWS cases with UPD for 11p15 or H19 hypermethylation, none of the <z:hpo ids='HP_0002898'>embryonal tumors</z:hpo> with imprinting defects at KCNQ1OT1 was a <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>This suggests that distinct <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> predisposition profiles result from dysregulation of the telomeric domain versus the centromeric domain and that these imprinting defects activate distinct genetic pathways for embryonal <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
</text></document>